LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Net Margin Growth (3y) (2019 - 2026)

Analysis

LivaNova (LIVN) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -641.00
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 420.00
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 484.00
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 459.00
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 941.00
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -1,024.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 574.00
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 300.00
10 LivaNova 4.51 Bn 3.99 Bn 273.67 Mn 2,742.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,742.00
Mar 31, 2026 358.00
Dec 31, 2025 795.00
Sep 30, 2025 5,001.00
Jun 30, 2025 122.00
Mar 31, 2025 -10,456.00
Dec 31, 2024 1,925.00
Sep 30, 2024 2,749.00
Jun 30, 2024 2,648.00
Mar 31, 2024 -181.00
Dec 31, 2023 11,048.00
Sep 30, 2023 359.00
Jun 30, 2023 4,867.00
Mar 31, 2023 -1,275.00
Dec 31, 2022 5,127.00
Sep 30, 2022 -5,447.00
Jun 30, 2022 1,703.00
Mar 31, 2022 718.00
Dec 31, 2021 6,901.00
Sep 30, 2021 -1,451.00